Cancer Forum/Musculoskeletal Research Group Tumor Board presentation at UCLA
“Tumor Grade & Neoadjuvant Therapy Impact The Establishment of Soft-Tissue Sarcoma Patient-Derived Orthotopic Xenografts (PDOX): A UCLA Sarcoma Program Prospective Clinical Trial”
By Tara Russell, M.D.
Research Follow/Surgical Resident
UCLA Department of Surgical Oncology
3:30 p.m., SM UCLA Conference Room #3
Objective: Feasibility of Personalized Oncology Care in Sarcoma Patients (CME credit)
Comments are closed.